Pharma News India

The approval is a green signal for the pharma company to market the product in the US.

New Delhi, December 19, 2012: Natco Pharma has received the approval from the US regulator, Food and Drug Administration (FDA) to market the anti-ulcer drug, Lansoprazole delayed release capsules in the US market.


Exports from pharmaceutical sector is expected to touch US$ 17 billion during FY 2012-13.

Hyderabad, December 19, 2012: Indian pharmaceutical exports are expected to post a 25 per cent growth during this financial year to touch US$ 17 billion. The growth is expected to be driven by the formulations and active pharmaceutical ingredients (API).


Pharma SMEs from Gujarat look to tap emerging economies like African and Latin American nations.

Ahmedabad, December 18, 2012: With a view to tap the high-margin markets like African and Latin American nations, small and medium sized pharma manufacturers from Gujarat have stepped up their efforts. As per estimates, these markets are growing at a compound annual growth rate of 30-3...


The proceeds from selling its stake in the infusion business will be used as fresh investment in Claris.

New Delhi, December 13, 2012: The Ahmedabad-based sterile injectables pharmaceutical firm, Claris Lifesciences has announced that the company will invest Rs 900 crore on the growth of business and pre-payment of the debt of the company.


The pharma exports from India have grown at a CAGR of 16 per cent over the last five years.

New Delhi, December 12, 2012: The growing dominance of Indian pharmaceutical industry on the global landscape is evident from the fact that the Indian pharma exports have registered a growth of 23.34 per cent in the last financial year i.e. 2011-12, as per Pharmaceuticals Export Promotion C...


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...